Specific Affiliate Activities

  • HCT Center

    Human Cell/Tissue (HCT) Centers provide a centralized, profitable operational base for regenerative clinics.

  • Medical Protocols

    Receive access to, or contribute towards, the latest library of modularized regenerative medicine protocols.

  • Equipment Sourcing

    Regen Med passes along research contracts, product discounts and further benefits from leading providers.

  • Training

    Schedule a private training session with our staff of experienced surgeons and technicians.

  • Data Collection

    Gain tools and services to help you responsibly capture and publish patient outcomes.


What are the principal benefits of Regen Med “Affiliate” status?

Regen Med provides ongoing support in terms of new RMP protocols, training, technology platforms, surgical techniques specific to particular RMP’s, marketing, patient referrals and similar matters.  It obtains and passes on to Affiliates the best available pricing on devices and products. (Regen Med is product agnostic, and charges no mark-up on products it procures on behalf of Affiliates.)

Also, Affiliates have the opportunity to participate in multi-center trials organized by or through Regen Med, joint paper publications and other forms of professional collaboration.

Affiliates may also benefit from local and international patient referrals developed through the Company’s website and other patient channels. Regen Med assists the Affiliate with on-line and off-line marketing materials for its RMP capabilities, directed to both professional and patient audiences.

Finally, Regen Med can provide centralized (or “distributed”) services to an Affiliate. In addition to marketing services, these can include support for IP protection and commercial development, legal structuring, IRB – approved study designs, telemedicine and IT solutions for data collection and/or outcomes follow-up, financing and other matters.

What is the relationship between an Affiliate and an HCT Center?

Regen Med strongly recommends the establishment of a physically segregated clinical Human Cells/Tissue Center (“HCT Center”) on the premises of an Affiliate to support the delivery of RMP’s. More detail on HCT Centers can be found here.

How does Regen Med make money in the context of its relationship with an Affiliate?

In all events, Regen Med seeks to align its financial interests with those of the Affiliate. It is a long-term partner. If desired by the Affiliate, Regen Med is prepared to co-invest — typically as a minority partner — in an HCT Center with the Affiliate and/or local partner. Where the Affiliate wishes to maintain full control of the HCT Center, Regen Med receives a fee based on RMP’s processed by the HCT Center. More details on pro-forma revenues from HCT Centers, including Regen Med fees, can be found here.

Latest Corporate Announcements

  • Establishing a Regenerative Medicine Center  at the Galeazzi Orthopedic Institute, Milan, Italy

    Establishing a Regenerative Medicine Center at the Galeazzi Orthopedic Institute, Milan, Italy

    Regen Med recently executed inCytes™ license and related agreements with the Galeazzi Orthopedic Institute (“IOG”), one of the largest orthopedic research/clinical centers in Europe.  IOG in turn is one of 18 hospitals owned by Gruppo San Donato (“GSD”) — 4 million patients annually, 5,100 beds, 4,000 physicians.

    Using inCytes™ as the backbone, IOG and GSD are consolidating under a separate brand — “REGAIN” —  the development, standardization and delivery of regenerative medicine procedures.  REGAIN is scheduled to commence operations this September in orthopedic, oral and plastic/reconstructive surgery, as well as physiatry and sports medicine.  Expansion of REGAIN activities to other disciplines will follow shortly thereafter.

    Regen Med will provide a number of services to support REGAIN, including clinical data collection and reports, education and training, coordination with vendors, studies/trials, payor reimbursement, product incubation and international patient referrals.

    For additional information, please refer to our Corporate Literature page, or contact us at

    Read more →
  • InCytes Software: Q2/17 Release

    InCytes Software: Q2/17 Release


    InCytes™ is an integrated software-as-a-service platform supporting the collection and utilization of data-sets underlying evidence-based medical therapies. Developed by an international network of scientific and clinical thought-leaders, the platform provides value to healthcare professionals, payors, researchers, industry, professional medical societies and regulators.

    InCytes’ longitudinal and verifiable data-sets can be used to analyze virtually any clinical path, protocol, indication or procedure – in an efficient, intuitive manner. It further supports the execution of studies/trials, cost/benefit analyses, decisions based on precision medicine, and other healthcare-delivery value assessments.

    In all, InCytes is much more than an electronic healthcare record or electronic data capture system. To learn more, please download our product brochure by clicking the link above.

    Read more →
  • Bringing Cell Therapies to the Clinic: Brochure Download

    Bringing Cell Therapies to the Clinic: Brochure Download

    Despite the broad potential of RMP’s, clinical translation has been uneven. Barriers to broader adoption include regulatory uncertainty, paucity of clinically relevant data, the dynamic nature of modern cell science, less than-ethical “stem cell” marketing, non-standardized protocols, uncertain revenue models, and inadequate education and training of healthcare professionals and patients alike. As with many major advances in medicine – hematology, IVF, orthopedic surgery to name but a few – broad adoption of RMP’s will require clinical/ scientific leadership, protocol standardization, professional and patient education, and regulatory and third party payor acceptance. Regen Med — comprising internationally recognized clinical and thought leaders in regenerative medicine — is dedicated to assisting hospitals as well as smaller medical practices address these issues. Being product agnostic, Regen Med is able to align its interests with its “Affiliates” in establishing approaches to regenerative medicine which are evidence based, regulatorily-compliant and economically sensible.

    To read more, please download our full brochure: HCTCenter_Brochure_DIGITAL

    Read more →
  • HCT Centers: Frequently Asked Questions Download

    Human Cell/Tissue Centers (“HCT”) support the delivery of regenerative medicine procedures in a manner designed to obtain consistent clinical results. Whether as a large teaching hospital, or small, specific practice, an HCT center is a reliable, profitable and regulatorily compliant assets for the establishment of a regenerative medicine practice. To learn more about HCT Centers and gain answers to frequently asked questions by our affiliates, please click here.

    Read more →